Walid Abi-Saab
CIK: 0001985973
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
uniQure N.V.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Oct 30, 2026QURE
uniQure N.V.
Award(A)Direct18.8K shares- - Jun 30, 2026QURE
uniQure N.V.
Exercise(M)Direct10K shares at avg. $5.59$56K - Jun 30, 2026QURE
uniQure N.V.
Sale(S)Direct10K shares at avg. $46.46$465K - Jun 30, 2026QURE
uniQure N.V.
Sale(S)Direct20K shares at avg. $46.40$928K - May 8, 2026QURE
uniQure N.V.
Sale(S)Direct25K shares at avg. $25.10$628K - May 8, 2026QURE
uniQure N.V.
Sale(S)Direct20K shares at avg. $25.00$500K - May 8, 2026QURE
uniQure N.V.
Exercise(M)Direct25K shares at avg. $5.59$140K - Mar 4, 2026QURE
uniQure N.V.
Award(A)Direct41.7K shares- - Mar 4, 2026QURE
uniQure N.V.
Sale(S)Direct808 shares at avg. $9.06$7K - Mar 2, 2026QURE
uniQure N.V.
Sale(S)Direct1.7K shares at avg. $9.95$17K - Jun 27, 2025QURE
uniQure N.V.
Sale(S)Direct1.5K shares at avg. $13.92$20K - Mar 4, 2025QURE
uniQure N.V.
Sale(S)Direct1.4K shares at avg. $10.29$14K - Mar 3, 2025QURE
uniQure N.V.
Award(A)Direct38K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 30, 2026 | QURE uniQure N.V. | Award(A) | 18,750 | - | $0 | Direct |
| Jun 30, 2026 | QURE uniQure N.V. | Exercise(M) | 10,000 | $5.59 | $55,900 | Direct |
| Jun 30, 2026 | QURE uniQure N.V. | Sale(S) | 10,000 | $46.46 | $464,600 | Direct |
| Jun 30, 2026 | QURE uniQure N.V. | Sale(S) | 20,000 | $46.40 | $928,000 | Direct |
| May 8, 2026 | QURE uniQure N.V. | Sale(S) | 25,000 | $25.10 | $627,500 | Direct |
| May 8, 2026 | QURE uniQure N.V. | Sale(S) | 20,000 | $25.00 | $500,000 | Direct |
| May 8, 2026 | QURE uniQure N.V. | Exercise(M) | 25,000 | $5.59 | $139,750 | Direct |
| Mar 4, 2026 | QURE uniQure N.V. | Award(A) | 41,700 | - | $0 | Direct |
| Mar 4, 2026 | QURE uniQure N.V. | Sale(S) | 808 | $9.06 | $7,320 | Direct |
| Mar 2, 2026 | QURE uniQure N.V. | Sale(S) | 1,660 | $9.95 | $16,517 | Direct |
| Jun 27, 2025 | QURE uniQure N.V. | Sale(S) | 1,466 | $13.92 | $20,407 | Direct |
| Mar 4, 2025 | QURE uniQure N.V. | Sale(S) | 1,350 | $10.29 | $13,891 | Direct |
| Mar 3, 2025 | QURE uniQure N.V. | Award(A) | 38,000 | - | - | Direct |
1-13 of 13 transactions
About Abi-Saab Walid
Abi-Saab Walid (SEC CIK 0001985973) files insider reports with the SEC as Chief Medical Officer of uniQure N.V. (QURE).
Signal8 holds 7 ownership filings by Abi-Saab Walid, all Form 4s, filed between Mar 5, 2025 and Nov 3, 2026. Those filings report 13 transactions, from Mar 3, 2025 to Oct 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Abi-Saab Walid's filings is in AMSTERDAM.
Recent filings by Abi-Saab Walid
- Oct 30, 2026: Grant or award of QURE shares (Form 4, code A).
- Jun 30, 2026: Option exercise of QURE shares (Form 4, code M).
- Jun 30, 2026: Open-market sales of QURE shares (2 lines, Form 4, code S).
- May 8, 2026: Open-market sales of QURE shares (2 lines, Form 4, code S).
- May 8, 2026: Option exercise of QURE shares (Form 4, code M).
Other insiders filing for uniQure N.V. (QURE)
- Kapusta Matthew C, CEO, Managing Director
- Kaye Jack, Director
- Balachandran Madhavan, Director
- Potts Jeannette, Chief Legal Officer
- Meek David D., Director
- Gut Robert, Director